Back to Search Start Over

LONG-TERM DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN TYPE 2 PATIENTS WITH/WITHOUT ALLERGIC.

Authors :
Sher, L.
Corren, J.
Pavord, I.
Pandit-Abid, N.
Radwan, A.
Jacob-Nara, J.
Deniz, Y.
Rowe, P.
Source :
Annals of Allergy, Asthma & Immunology; 2022 Supplement, Vol. 129 Issue 5, pS44-S45, 2p
Publication Year :
2022

Details

Language :
English
ISSN :
10811206
Volume :
129
Issue :
5
Database :
Supplemental Index
Journal :
Annals of Allergy, Asthma & Immunology
Publication Type :
Academic Journal
Accession number :
159656757
Full Text :
https://doi.org/10.1016/j.anai.2022.08.628